Jilin Aodong Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 43.2% in First Three Quarters of 2023

Jilin Aodong Pharmaceutical Group Co.,Ltd. (吉林敖东药业集团股份有限公司) (000623.SZ) reported a net profit of 1.3 billion yuan in the first three quarters of 2023, up 43.2% year-on-year.

Meanwhile, the company posted 2.4 billion yuan in revenue, up 23.1% year-on-year.

At the end of the reporting period, it had 32.2 billion yuan in total assets and 4.8 billion yuan in total liabilities, with a liability-to-asset ratio of 15%.